Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis

doi:10.3748/wjg.v25.i27.3607

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6790)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

491

WORD

203

HTML

3210

Figures (1-4)

193

Tables (1-3)

144

Sum=4241

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1011

Download

1538

Sum=2549

Jul 21, 2019 (publication date) through Apr 19, 2024

Times Cited of This Article

Times Cited (13)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jul 21, 2019; 25(27): 3607-3618
Published online Jul 21, 2019. doi: 10.3748/wjg.v25.i27.3607

Open in New Tab Full Size Figure Download Figure

Figure 1 Cumulative survival stratified by Barcelona Clinic Liver Cancer staging in the overall cohort. BCLC: Barcelona clinic liver cancer.

Open in New Tab Full Size Figure Download Figure

Figure 2 Characteristics and management of patients treated with transarterial chemoembolization. A: Kaplan Meier survival curves according to Barcelona Clinic Liver Cancer stage and treatment with/without trans-arterial chemoembolization; B: Survival according to radiological response after the first transarterial chemoembolization (TACE) evaluated by RECIST 1.1 criteria. BCLC: Barcelona clinic liver cancer.

Open in New Tab Full Size Figure Download Figure

Figure 3 Corresponding survival curves for patients treated with Sorafenib stratified by Barcelona Clinic Liver Cancer stages. BCLC: Barcelona clinic liver cancer.

Open in New Tab Full Size Figure Download Figure

Figure 4 Survival in Barcelona Clinic Liver Cancer stage B patients under tumor progression with the sequential treatment of transarterial chemoembolization-sorafenib. BCLC: Barcelona clinic liver cancer.

Citation: Piñero F, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Romero G, Ameigeiras B, D’Amico C, Gaite L, Bermúdez C, Reggiardo V, Colombato L, Gadano A, Silva M. Intermediate-advanced hepatocellular carcinoma in Argentina: Treatment and survival analysis. World J Gastroenterol 2019; 25(27): 3607-3618
URL: https://www.wjgnet.com/1007-9327/full/v25/i27/3607.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i27.3607